Suppr超能文献

[1例肛管鳞状细胞癌肝门淋巴结转移放化疗后采用S-1/顺铂治疗长期生存的病例]

[A Case of Long-Term Survival with S-1/Cisplatin for Liver Hilum Lymph Node Metastasis of Anal Canal Squamous Cell Carcinoma after Chemoradiotherapy].

作者信息

Matsuki Goshi, Nakajima Takayoshi, Ichise Noriko, Nomura Kazunori, Fujikawa Masataka, Kasai Meidai, Okamoto Ryo, Ikuta Shinichi, Nakamoto Yoshihiko, Aihara Tsukasa, Kajimoto Noriko, Kakuno Ayako, Yanagi Hidenori, Yamanaka Naoki

机构信息

Dept. of Surgery, Meiwa Hospital.

出版信息

Gan To Kagaku Ryoho. 2022 Dec;49(13):1739-1741.

Abstract

A 70-year-old woman was admitted to a local hospital because of anal pain during defecation. Anoscopy revealed an anal mass lesion, and the patient was referred to our hospital. Colonoscopy revealed an anal canal tumor with ulceration, and biopsy showed squamous cell carcinoma. The patient was treated with chemoradiotherapy(chemotherapy with capecitabine plus mitomycin C and 54 Gy radiation in the anal region)and achieved complete response. However, metastatic recurrence was detected in a lymph node in the hepatic hilar region. We administered an S-1/CDDP combination chemotherapy (5 courses). For 3 years and 5 months since the initial treatment, the patient survived with no signs of recurrence. We report a rare case of long-term survival with S-1/CDDP for distant metastasis of anal canal squamous cell carcinoma after chemoradiotherapy.

摘要

一名70岁女性因排便时肛门疼痛入住当地医院。肛门镜检查发现肛门有肿物病变,该患者被转诊至我院。结肠镜检查发现肛管肿瘤伴溃疡,活检显示为鳞状细胞癌。患者接受了放化疗(卡培他滨加丝裂霉素C化疗及肛门区域54 Gy放疗)并获得完全缓解。然而,在肝门区淋巴结检测到转移复发。我们给予S-1/顺铂联合化疗(5个疗程)。自初始治疗以来3年零5个月,患者存活且无复发迹象。我们报告了1例肛管鳞状细胞癌放化疗后远处转移经S-1/顺铂治疗长期存活的罕见病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验